← Browse by Condition
Medical Condition

idiopathic inflammatory myopathy

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3, Phase 1

ClinicalMetric aggregates all active clinical trials for idiopathic inflammatory myopathy from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT06154252 Phase 2, Phase 3
Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Enrollment
74 pts
Location
United States, Unite...
Sponsor
Cabaletta Bio
View Trial →
NCT05869955 Phase 1
Recruiting

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Enrollment
270 pts
Location
United States, Belgi...
Sponsor
Juno Therapeutics, Inc., a Bri...
View Trial →
NCT07085104 Phase 1
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Enrollment
54 pts
Location
United States, Canad...
Sponsor
Allogene Therapeutics
View Trial →